title: [Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV].
authors.affiliation: Klinik für Pneumologie, Ruppiner Klinikum GmbH, Neuruppin, Deutschland.
authors.forename: Karl-Matthias
authors.initials: KM
authors.lastname: Deppermann
authors.forename: Rudolf M
authors.initials: RM
authors.lastname: Huber
authors.forename: Eckart
authors.initials: E
authors.lastname: Laack
authors.forename: Martin
authors.initials: M
authors.lastname: Reck
authors.forename: Monika
authors.initials: M
authors.lastname: Serke
authors.forename: Joachim
authors.initials: J
authors.lastname: von Pawel
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D002986:Clinical Trials as Topic; D004358:Drug Therapy / Q000379:methods* / Q000639:trends; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends
chemical_list: D000970:Antineoplastic Agents